Cite
APA Citation
Zeidan, A. M., Mearns, E. S., Ng, C., Shah, A., Lamarre, N., Yellow-Duke, A., Alrawashdh, N., Yang, B., Cheng, W., Bui, C. N., & Svensson, A. (n.d.). p766: CLINICAL OUTCOMES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES RECEIVING HYPOMETHYLATING AGENTS: A LARGE POPULATION-BASED ANALYSIS. HemaSphere, 6, 661–662. http://access.bl.uk/ark:/81055/vdc_100158014066.0x00000d